BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 16923162)

  • 1. RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo.
    Ulbricht U; Eckerich C; Fillbrandt R; Westphal M; Lamszus K
    J Neurochem; 2006 Sep; 98(5):1497-506. PubMed ID: 16923162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of the receptor protein tyrosine phosphatase beta with a monoclonal antibody delays tumor growth in a glioblastoma model.
    Foehr ED; Lorente G; Kuo J; Ram R; Nikolich K; Urfer R
    Cancer Res; 2006 Feb; 66(4):2271-8. PubMed ID: 16489031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotrophin stimulates tyrosine phosphorylation of beta-adducin through inactivation of the transmembrane receptor protein tyrosine phosphatase beta/zeta.
    Pariser H; Perez-Pinera P; Ezquerra L; Herradon G; Deuel TF
    Biochem Biophys Res Commun; 2005 Sep; 335(1):232-9. PubMed ID: 16105548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional comparison of long and short splice forms of RPTPbeta: implications for glioblastoma treatment.
    Lorente G; Nelson A; Mueller S; Kuo J; Urfer R; Nikolich K; Foehr ED
    Neuro Oncol; 2005 Apr; 7(2):154-63. PubMed ID: 15831233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta-signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin.
    Pariser H; Ezquerra L; Herradon G; Perez-Pinera P; Deuel TF
    Biochem Biophys Res Commun; 2005 Jul; 332(3):664-9. PubMed ID: 15925565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase beta (RPTPbeta) to tenascin C.
    Adamsky K; Schilling J; Garwood J; Faissner A; Peles E
    Oncogene; 2001 Feb; 20(5):609-18. PubMed ID: 11313993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas.
    Ulbricht U; Brockmann MA; Aigner A; Eckerich C; Müller S; Fillbrandt R; Westphal M; Lamszus K
    J Neuropathol Exp Neurol; 2003 Dec; 62(12):1265-75. PubMed ID: 14692702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta.
    Mikelis C; Sfaelou E; Koutsioumpa M; Kieffer N; Papadimitriou E
    FASEB J; 2009 May; 23(5):1459-69. PubMed ID: 19141530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for receptor tyrosine phosphatase zeta in glioma cell migration.
    Müller S; Kunkel P; Lamszus K; Ulbricht U; Lorente GA; Nelson AM; von Schack D; Chin DJ; Lohr SC; Westphal M; Melcher T
    Oncogene; 2003 Oct; 22(43):6661-8. PubMed ID: 14555979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatio-temporal characterization of the pleiotrophinergic system in mouse cerebellum: evidence for its key role during ontogenesis.
    Basille-Dugay M; Hamza MM; Tassery C; Parent B; Raoult E; Bénard M; Raisman-Vozari R; Vaudry D; Burel DC
    Exp Neurol; 2013 Sep; 247():537-51. PubMed ID: 23454176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of receptor-like protein tyrosine phosphatase zeta/RPTPbeta and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration.
    Maeda N; Noda M
    J Cell Biol; 1998 Jul; 142(1):203-16. PubMed ID: 9660874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contactin is expressed in human astrocytic gliomas and mediates repulsive effects.
    Eckerich C; Zapf S; Ulbricht U; Müller S; Fillbrandt R; Westphal M; Lamszus K
    Glia; 2006 Jan; 53(1):1-12. PubMed ID: 16078236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses.
    Wu M; Huang C; Li X; Li X; Gan K; Chen Q; Tang Y; Tang K; Shen S; Li G
    J Cell Physiol; 2008 Jan; 214(1):65-74. PubMed ID: 17541939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide corresponding to the C-terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro.
    Mikelis C; Lamprou M; Koutsioumpa M; Koutsioubas AG; Spyranti Z; Zompra AA; Spiliopoulos N; Vradis AA; Katsoris P; Spyroulias GA; Cordopatis P; Courty J; Papadimitriou E
    J Cell Biochem; 2011 Jun; 112(6):1532-43. PubMed ID: 21344482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factor.
    Koutsioumpa M; Poimenidi E; Pantazaka E; Theodoropoulou C; Skoura A; Megalooikonomou V; Kieffer N; Courty J; Mizumoto S; Sugahara K; Papadimitriou E
    Mol Cancer; 2015 Feb; 14(1):19. PubMed ID: 25644401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of GIT1/Cat-1 as a substrate molecule of protein tyrosine phosphatase zeta /beta by the yeast substrate-trapping system.
    Kawachi H; Fujikawa A; Maeda N; Noda M
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6593-8. PubMed ID: 11381105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.
    Nakamura H; Siddiqui SS; Shen X; Malik AB; Pulido JS; Kumar NM; Yue BY
    Mol Vis; 2004 Oct; 10():703-11. PubMed ID: 15475878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
    Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM
    J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
    Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
    Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
    Lakka SS; Gondi CS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Rao JS
    Oncogene; 2004 Jun; 23(27):4681-9. PubMed ID: 15122332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.